# Utility of Regadenoson Low-dose Dynamic Computed Tomography for Myocardial Perfusion Assesment (ULYSSES Study).

> **NCT03917199** · — · COMPLETED · sponsor: **National Institute of Cardiology, Warsaw, Poland** · enrollment: 60 (actual)

## Conditions studied

- Myocardial Perfusion Imaging
- Computed Tomography
- Coronary Artery Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03917199
- **Lead sponsor:** National Institute of Cardiology, Warsaw, Poland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2019-07
- **Final completion:** 2019-07-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03917199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03917199, "Utility of Regadenoson Low-dose Dynamic Computed Tomography for Myocardial Perfusion Assesment (ULYSSES Study).". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03917199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*